News

AFT extends Maxigesic® IV license in South America

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has signed an exclusive Maxigesic® IV licensing agreement for eight new European markets.

Read More

AFT licenses Maxigesic® IV in the US

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has signed an exclusive Maxigesic® IV licensing agreement for eight new European markets.

Read More

AFT licenses Pascomer® for Europe

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has signed a new commercialisation and development agreement for its orphan drug Pascomer®

Read More

Maxigesic® IV licensed in eight new European markets

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has signed an exclusive Maxigesic® IV licensing agreement for eight new European markets.

Read More

AFT confirms demonstration of 24-hour efficacy for Crystawash extend hand sanitiser

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces independent laboratories have found that its new Crystawash Extend Hand Sanitiser

Read More

AFT builds North American momentum

Diversified pharmaceutical company appoints new north American-based director and launches Maxigesic® in Canada.

Read More

Management financial discussion and analysis for the half year to 30 September 2020

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces continued growth in revenue and normalised earnings as it benefits from growth across its portfolio

Read More

Financial results for half year ended 30 September 2020

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces continued growth in revenue and normalised earnings as it benefits from growth across its portfolio.

Read More

AFT opening European office, signs new partners for maxigesic iv and oral range

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) announces the establishment of a new subsidiary in Ireland

Read More

AFT welcomes us fda complete response letter

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has received a US Food and Drug Administration (FDA) complete response letter (CRL).

Read More

AFT appoints Anita Baldauf as a director

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) has today appointed Anita Baldauf as a non-executive director.

Read More

AFT and Setek sign supply agreement

Agreement covers pharmaceutical-grade medicinal cannabis ingredients for products initially targeted for Australia and New Zealand

Read More